866-997-4948(US-Canada Toll Free)

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Egypt

Published By :

GlobalData

Published Date : Dec 2017

Category :

Pharmaceutical

No. of Pages : 133 Pages

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Egypt

Summary

GlobalData, the industry analysis specialist, has released its latest report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Egypt". The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Egypt. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of Egypt. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalDatas team of industry experts.

In 2016, Egypt population was approximately at 90.2 million. Egypt has the largest pharmaceutical manufacturing base in the Middle East and North Africa (MENA) region, representing around 30% of the regional market. Its pharmaceutical market was worth $2.31 billion in 2009 and an estimated $5.43 billion in 2016, having grown at a Compound Annual Growth Rate (CAGR) of 14.1%. The market is estimated to reach $10.50 billion in 2021. The Egyptian medical device market was valued at $0.70 billion in 2009 and is one of the growing industries in the healthcare sector, due to the aging population and consequent increase in demand for healthcare products and services. It grew to $0.95 billion at a CAGR of 4.2% between 2009 and 2016 and is forecast to reach $1.23 billion in 2021. The segments expected to experience high growth are cardiovascular devices, orthopedic device, drug delivery devices, in vitro diagnostics and healthcare IT.

These positive trends can primarily be attributed to -
- Government initiatives to develop and modernize government hospitals and therapeutic centres in various parts of the country
- Increasing awareness in the medical community and the general population regarding early disease detection and diagnosis, leading to higher rates of adoption of treatments and healthcare.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Egypt, and includes -
- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market (GSK, Novartis, Sanofi, Egyptian International Pharmaceutical Industries Company (EIPICO) and South Egypt Drug Industries Company (SEDICO))
- An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices
- Detailed analysis of the political and economic environment, covering economic indicators, demographics, healthcare infrastructure and healthcare expenditure
- An overview of the opportunities for and challenges to growth in the Egyptian healthcare market

Reasons to buy

This report will enhance your decision-making capability by allowing you to -
- Develop business strategies by understanding the trends shaping and driving the Egyptian healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership
- Identify, understand, and capitalize on the opportunities and challenges in the Egyptian healthcare market
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 5
2 Executive Summary 6
3 Introduction 10
3.1 GlobalData Report Guidance 10
4 Overview of the Pharmaceutical and Medical Device Markets 11
4.1 Pharmaceutical Market 11
4.1.1 Market Overview 11
4.1.2 Pharmaceutical Imports and Exports 15
4.1.3 Supply Channels 16
4.1.4 Market Segments 17
4.1.5 Overview of Major Therapeutic Areas 19
4.1.6 Major Players 20
4.2 Medical Device Market 44
4.2.1 Market Overview 44
4.2.2 Overview of Top Five Segments 46
4.2.3 Major Players 52
4.3 Market Drivers and Barriers 70
4.3.1 Drivers 70
4.3.2 Barriers 70
5 Market Access 72
5.1 Overview of Healthcare System 72
5.2 Reimbursement and Payer Landscape 72
5.3 Drug Reimbursement Process 72
5.3.1 Overview of Insurance Providers 75
5.3.2 Patient Share in Healthcare Spending 77
5.3.3 Price Trend in Healthcare Services 78
5.3.4 Pricing Policies 79
5.4 Regulatory Landscape 80
5.4.1 Overview of Regulatory Agencies 80
5.4.2 Market Authorization Procedure for Pharmaceutical Products 81
5.4.3 Market Authorization Procedure for Medical Devices 87
5.4.4 Licensing Process for Pharmaceutical and Medical Device Manufacturing 89
5.4.5 Licensing Process for Pharmaceutical Imports and Exports 91
5.4.6 Intellectual Property Rights 92
5.4.7 Clinical Trial Regulations 93
5.4.8 Pharmaceutical Advertising Regulation 94
5.4.9 Pharmacy Regulations 95
5.4.10 Labeling and Packaging Regulations 96
6 Country Healthcare Landscape 98
6.1 Healthcare Policy Initiatives 98
6.2 Healthcare Infrastructure 100
6.2.1 Healthcare Facilities 100
6.2.2 Healthcare Parameters 103
6.2.3 Healthcare Personnel 111
6.2.4 Environmental Health 114
6.3 Healthcare Expenditure 117
6.3.1 Overview 117
6.3.2 Public-Private Sector Share 118
6.4 Trade Associations 118
6.4.1 Arab Union of Manufacturers of Pharmaceuticals and Medical Appliances 118
6.4.2 Federation of Egyptian Industries 119
6.4.3 Egyptian Pharmaceutical Students Federation 119
6.5 Trade Fairs 119
7 Opportunities and Challenges 120
7.1 Opportunities 120
7.2 Challenges 120
8 Appendix 122
8.1 Abbreviations 122
8.2 Bibliography 123
8.3 Research Methodology 131
8.3.1 Coverage 131
8.3.2 Secondary Research 132
8.3.3 Forecasts 132
8.3.4 Expert Panel 133
8.4 Contact Us 133
8.5 Disclaimer 133

1.1 List of Tables
Table 1: Pharmaceutical Market, Egypt, Revenue ($bn), 2009-2016 13
Table 2: Pharmaceutical Market, Egypt, Revenue Forecast ($bn), 2017-2021 14
Table 3: Pharmaceutical Market, Egypt, Pharmaceutical Exports and Imports ($bn), 2009-2016 15
Table 4: Pharmaceutical Market, Egypt, Price Mark-ups, 2016 17
Table 5: Pharmaceutical Market, Egypt, Annual Cost of Treatment ($m), 2016 19
Table 6: Pharmaceutical Market, Novartis, Major Products, 2017 27
Table 7: Pharmaceutical Market, Novartis, Planned Filings, 2017-2020 29
Table 8: Sanofi, Global, Major Products, Revenue ($bn) and Annual Growth (%), 2016 35
Table 9: Pharmaceutical Market, Sanofi, Global, Late-Stage Pipeline, 2017 35
Table 10: Medical Device Market, Egypt, Revenue ($bn), 2009-2016 44
Table 11: Medical Device Market, Egypt, Revenue Forecast ($bn), 2017-2021 45
Table 12: Medical Device Market, Egypt, Revenue ($m) and Market Share (%) by Segment, 2016 46
Table 13: Cardiovascular Devices Market, Egypt, Revenue ($m), 2009-2016 47
Table 14: Wound Care Management Market, Egypt, Revenue ($m), 2009-2016 48
Table 15: Orthopedic Devices Market, Egypt, Revenue ($m), 2009-2016 49
Table 16: Ophthalmic Devices Market, Egypt, Revenue of Major Players ($m), 2009-2016 50
Table 17: Diagnostic Imaging Market, Egypt, Revenue ($m), 2009-2016 51
Table 18: Medical Device Market, Egypt, Major Products by Segment, 2016 52
Table 19: Roche, Global, Major Products, 2015 56
Table 20: Medical Device Market, Roche, Global, Late-Stage Pipeline, 2016 56
Table 21: Market Access, Egypt, HIO Beneficiaries, Premium Rates (%), 2016 76
Table 22: Market Access, Egypt, Out-of-Pocket Expenditure as Percentage of Total Expenditure on Health (%), 2009-2015 77
Table 23: Market Access, Egypt, Healthcare Inflation (%), 2009-2016 78
Table 24: Healthcare Infrastructure, Egypt, Number of Hospitals, 2009-2015 100
Table 25: Healthcare Infrastructure, Egypt, Number of Government and Private Hospitals, 2009-2015 101
Table 26: Healthcare Infrastructure, Egypt, Health Centers, 2009-2015 102
Table 27: Healthcare Infrastructure, Egypt, Hospital Beds (000), 2009-2015 103
Table 28: Demographics, Egypt, Life Expectancy at Birth (years), 2009-2016 104
Table 29: Demographics, Egypt, Immunization Rate (%), 2009-2016 105
Table 30: Demographics, Egypt, Major Causes of Mortality (000), 2015 106
Table 31: Demographics, Egypt, Major Causes of Male Mortality (000), 2015 107
Table 32: Demographics, Egypt, Major Causes of Female Mortality (000), 2015 108
Table 33: Demographics, Egypt, Disability-Adjusted Life Years by Major Disease (000), 2015 110
Table 34: Healthcare Infrastructure, Egypt, Physicians (000), 2009-2015 111
Table 35: Healthcare Infrastructure, Egypt, Dentists (000), 2009-2015 112
Table 36: Healthcare Infrastructure, Egypt, Pharmacists (000), 2009-2015 113
Table 37: Healthcare Infrastructure, Egypt, Nurses (000), 2009-2015 114
Table 38: Healthcare Infrastructure, Egypt, PM2.5 (g per m3), 2009-2015 115
Table 39: Healthcare Infrastructure, Egypt, CO2 Emissions (million tons), 2009-2015 116
Table 40: Healthcare Expenditure, Egypt, Healthcare Expenditure as Percentage of GDP (%), 2009-2016 117
Table 41: Healthcare Expenditure, Egypt, Public-Private Share (%), 2009-2015 118
Table 42: Healthcare Expenditure, Egypt, Major Healthcare Trade Fairs, 2017 119

1.2 List of Figures
Figure 1: Pharmaceutical Market, Egypt, Revenue ($bn), 2009-2021 7
Figure 2: Medical Device Market, Egypt, Revenue ($bn), 2009-2021 8
Figure 3: Country Profile, Egypt, 2017 9
Figure 4: Pharmaceutical Market, Egypt, Revenue ($bn), 2009-2016 13
Figure 5: Pharmaceutical Market, Egypt, Revenue Forecast ($bn), 2017-2021 14
Figure 6: Pharmaceutical Market, Egypt, Pharmaceutical Exports and Imports ($bn), 2009-2016 15
Figure 7: Pharmaceutical Market, Egypt, Supply Channels, 2016 16
Figure 8: Pharmaceutical Market, Egypt, Annual Cost of Treatment ($m), 2016 19
Figure 9: Medical Device Market, Egypt, Revenue ($bn), 2009-2016 44
Figure 10: Medical Device Market, Egypt, Revenue Forecast ($bn), 2017-2021 45
Figure 11: Medical Device Market, Egypt, Revenue by Segment ($m), 2016 46
Figure 12: Cardiovascular Devices Market, Egypt, Revenue ($m), 2009-2016 47
Figure 13: Wound Care Management Market, Egypt, Revenue ($m), 2009-2016 48
Figure 14: Orthopedic Devices Market, Egypt, Revenue ($m), 2009-2016 49
Figure 15: Ophthalmic Devices Market, Egypt, Revenue ($m), 2009-2016 50
Figure 16: Diagnostic Imaging Market, Egypt, Revenue ($m), 2009-2016 51
Figure 17: Pharmaceutical Market, Egypt, Drivers and Barriers, 2017 71
Figure 18: Market Access, Egypt, Key Influencers in Decision-Making Process in Healthcare System, 2012 74
Figure 19: Market Access, Egypt, Public Insurance Reform Milestones, 1964-2017 75
Figure 20: Market Access, Egypt, Out-of-Pocket Expenditure as Percentage of Total Expenditure on Health (%), 2009-2015 77
Figure 21: Market Access, Egypt, Healthcare Inflation (%), 2009-2016 78
Figure 22: Egyptian Drug Authority, Organization Chart, Egypt, 2017 81
Figure 23: New Drug Approval Process, Egypt, 2013 83
Figure 24: Biosimilar Registration for Imported Products, Egypt, 2017 84
Figure 25: Biosimilar Registration for Locally Manufactured Products for Case I and II, Egypt, 2017 86
Figure 26: Biosimilar Registration for Locally Manufactured Products for Case III, Egypt, 2017 87
Figure 27: Licensing Process for Manufacturing Site, Egypt, 2017 90
Figure 28: Licensing Process for New Production Line, Egypt, 2017 90
Figure 29: Healthcare Infrastructure, Egypt, Number of Hospitals, 2009-2015 100
Figure 30: Healthcare Infrastructure, Egypt, Number of Government and Private Hospitals, 2009-2015 101
Figure 31: Healthcare Infrastructure, Egypt, Health Centers, 2009-2015 102
Figure 32: Healthcare Infrastructure, Egypt, Hospital Beds (000), 2009-2015 103
Figure 33: Demographics, Egypt, Life Expectancy at Birth (years), 2009-2016 104
Figure 34: Demographics, Egypt, Immunization Rate (%), 2009-2016 105
Figure 35: Demographics, Egypt, Major Causes of Mortality (000), 2015 106
Figure 36: Demographics, Egypt, Major Causes of Male Mortality (000), 2015 107
Figure 37: Demographics, Egypt, Major Causes of Female Mortality (000), 2015 108
Figure 38: Demographics, Egypt, Disability-Adjusted Life Years by Major Disease (000), 2015 109
Figure 39: Healthcare Infrastructure, Egypt, Physicians (000), 2009-2015 111
Figure 40: Healthcare Infrastructure, Egypt, Dentists (000), 2009-2015 112
Figure 41: Healthcare Infrastructure, Egypt, Pharmacists (000), 2009-2015 113
Figure 42: Healthcare Infrastructure, Egypt, Nurses (000), 2009-2015 114
Figure 43: Healthcare Infrastructure, Egypt, PM2.5 (g per m3), 2009-2015 115
Figure 44: Healthcare Infrastructure, Egypt, CO2 Emissions (million tons), 2009-2015 116
Figure 45: Healthcare Expenditure, Egypt, Healthcare Expenditure as Percentage of GDP (%), 2009-2016 117
Figure 46: Healthcare Expenditure, Egypt, Public-Private Share (%), 2009-2015 118
Figure 47: Healthcare Market, Egypt, Opportunities and Challenges, 2017 121

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *